{{Oxford/Loader}}
{{Oxford}}
<html lang="en">

<!-- THIS IS WHERE THE HTML BEGINS -->

<body>
    <section id="banner">
        <div class="container" style="width:100%; padding-right:0; padding-left:0;">
          <div class="row">
            <div class="col-md-12">
          <div class="inner" style="background-image: url('https://2019.igem.org/wiki/images/6/6b/T--Oxford--Sponsors_Bear.jpeg'); background-size: cover;">
            <div class=image_faded_overlay" style="background-color: lightskyblue; opacity:0.2">
            <div class="translucent-back" style="height: 400px;">
            </div>
          </div>
          <div class="banner_overlay_text">
            Results
          </div>
          </div>
  
        </div>
      </div>
    </div>
        </section>

      <section id="n1">
        <div class="container">
          <div class="row">
            <div class=".col-md-8 .offset-md-2">
  
                <h2> Functionality of &Phi;CD27L Endolysin </h2>

                <h4>The CD27L endolysin is a critical component of our system, as it acts as the agent of <i>C. difficile</i> lysis. Three parts were tested throughout this sub-section of project—they are summarised for clarity in Table 1.</h4>
                <br>
                <div class="panel-group">
                    <div class="panel panel-default">
                    <div class="panel-heading">
                      <h4 class="panel-title">
                        <a data-toggle="collapse" href="#Table1">Table 1: Different Constructs of CD27L Endolysin in pET28A Expression Vector</a>
                      </h4>
                    </div>
                    <div id="Table1" class="panel-collapse collapse">
                      <centre><div class="panel-body">
        
                          <div class="table-responsive">
                              <table class="table">
                                <thead>
                                  <tr>
                                    <th>Construct Name</th>
                                    <th>Construct</th>
                                    <th>Part Number</th>
                    
                                  </tr>
                                </thead>
                                <tbody>
                                  <tr>
                                    <td>Dundee-CD27L</td>
                                    <td><i>Hcp</i>-HA_Tag- CD27L<sub>1-179</sub></td>
                                    <td>BBa_K895004</td>
                                  </tr>

                                  <tr>
                                    <td>CD27L</td>
                                    <td>6His-SpyTag-CD27L</td>
                                    <td>BBa_K3183200</td>
                                  </tr>
                                    
                                  <tr>
                                    <td>CD27L<sub>1-179</sub></td>
                                    <td>6His-SpyTag-CD27L<sub>1-179</sub></td>
                                    <td>BBa_K3183201</td>
                                  </tr>
                    
                                </tbody>
                              </table>
                            </div>
              </div></centre>
          </div>
          </div>
          </div>

          <h4>We wanted to optimise the killing efficacy of the endolysin. Thus, we sought out the endolysin in an existing part made by the 2012 iGEM Team Dundee. This part (Dundee-CD27L<sub>1-179</sub>) was comprised of CD27L<sub>1-179</sub> endolysin linked to the hcp Type VI secretion tag via an haemagglutinin (HA) epitope tag <a href=”http://parts.igem.org/Part:BBa_K895004”>(BBa_K895004)</a>. </h4>
          <h4>After multiple attempts at expression, we were unable to express the protein, with further information on the <a href=”https://2019.igem.org/Improve>Part Improvement</a> page.  Fig. 1 provides a comparison between expression of the full-length endolysin, CD27L and the 2012 Dundee iGEM part BBa_K895004.</h4>

          <div class="panel-group">
              <div class="panel panel-default">
              <div class="panel-heading">
                <h4 class="panel-title">
                  <a data-toggle="collapse" href="#CD27L_Fig1">Fig 1: SDS-PAGE Gel Comparing CD27L Endolysin Samples with Dundee-CD27L Samples</a>
                </h4>
              </div>
              <div id="CD27L_Fig1" class="panel-collapse collapse">
                <centre><div class="panel-body">
                    <img src="" style="width: 100%;" alt="Fig 1: SDS-PAGE Gel Comparing CD27L Endolysin Samples with Dundee-CD27L Samples">
          </div></centre>
          </div>
          </div>
          </div>

          <h4>Regardless, expression of the full-length CD27L expression was successful as shown in Fig.1 and this was quantitatively verified via mass spectrometry as shown in Fig. 2.</h4>

          <div class="panel-group">
              <div class="panel panel-default">
              <div class="panel-heading">
                <h4 class="panel-title">
                  <a data-toggle="collapse" href="#CD27L_Fig2">Fig. 2: Mass Spectrometry of CD27L Endolysin Following Ni-NTA Purification</a>
                </h4>
              </div>
              <div id="CD27L_Fig2" class="panel-collapse collapse">
                <centre><div class="panel-body">
                    <img src="" style="width: 100%;" alt="Fig. 2: Mass Spectrometry of CD27L Endolysin Following Ni-NTA Purification">
          </div></centre>
          </div>
          </div>
          </div>

          <h4>Given this outcome, we decided to express only the truncated CD27L<sub>1-179</sub> endolysin, removing the hcp Type VI secretion tag which we assumed to have interfered with expression. In contrast, successful expression occurred for this new part BBa_K31830012, as shown in Figure 3.</h4>

          <h4>Due to safety concerns, our endolysin killing assays could only be carried out on on <i>Bacillus subitlis</i>, a Category 1 bacteria as opposed to <i>Clostridium difficile</i>, a Category 2 bacteria. <i>B. subtilis</i> has a similar peptidoglycan layer to <i>C. difficile</i>, allowing us to quantify killing data. </h4>

          <div class="panel-group">
              <div class="panel panel-default">
              <div class="panel-heading">
                <h4 class="panel-title">
                  <a data-toggle="collapse" href="#CD27L_Fig3">Figure 3: SDS-PAGE  Protein Purification Gels of CD27L & CD27L<sub>1-179</sub> using Ni-NTA Affinity Chromatography</a>
                </h4>
              </div>
              <div id="CD27L_Fig3" class="panel-collapse collapse">
                <centre><div class="panel-body">
                      <div class="container">
                        <div class="row">
                          <div class="col-md-6">
                              <img src="" style="width: 100%;" alt="Fig. 3.1: SDS-PAGE Protein Purification Gel of CD27L using Ni-NTA Affinity Chromatography">
                          </div>
                          <img src="" style="width: 100%;" alt="Fig. 3.2: SDS-PAGE Protein Purification Gel of CD27L<sub>1-179</sub> using Ni-NTA Affinity Chromatography">
                          <div class="col-md-6">


                          </div>
                        </div>
                      </div>
                   
          </div></centre>
          </div>
          </div>
          </div>

          <h4></h4>



</div>
</div>
</div>
</section>

<style>
    .column {
  float: left;
  width: 25%;
  padding: 5px;
}
</style>

</body>
</html>
{{Oxford/Footer}}
